SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?


To: Art Vandelay AIA who wrote (2561)4/28/1999 4:55:00 PM
From: Biomaven  Read Replies (2) | Respond to of 10280
 
Art,

Zyrtec generics can't enter the market until 2007.

Thanks - I hadn't realized this is another of those 5 year extension deals like sibutramine. Of course it remains to be seen if Knoll and Pfizer agree with SEPR's legal reasoning on this issue. My guess would be that they won't concede the issue without a fight - any more than companies allow generics to enter the market without a fight.

Peter